Reaktionsgleichung
[CH2:1]([N:3]1[C:9]2[CH:10]=[CH:11][CH:12]=[CH:13][C:8]=2[C:7](=O)[N:6]2[CH2:15][CH2:16][CH2:17][CH:5]2[C:4]1=[O:18])[CH3:2].C(N1C(=O)OC(=O)C2=CC=CC=C12)C.N1CCC[C@H]1C(O)=O.C1C=CN2C(=O)C3C=CC=CC=3NC(=O)C=12>CO>[CH2:1]([N:3]1[C:9]2[CH:10]=[CH:11][CH:12]=[CH:13][C:8]=2[CH2:7][N:6]2[CH2:15][CH2:16][CH2:17][CH:5]2[C:4]1=[O:18])[CH3:2]Komponenten
6
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
When (+) 10-ethyl-1,2,3,11a-tetrahydro-5 H-pyrrolo[2,1-c] [1,4] benzodiazepin-5,11(10H)-dione, melting point 138° -140°C., (prepared as described above by reacting N-ethylisatoic anhydride with L-proline) is substituted for (+)-1,2,3,11 a-tetrahydro-10-methyl-[5H-pyrrolo [2,1-c] [1,4] benzodiazepin-5,11 -(10H)-dione in the procedure of Example 1, the above compound is obtained. The hydrochloride salt melts at 233°-235°C., [α]D 25 + 415° (0.9% in methanol).
Aufarbeitung
- customthe above compound is obtained
Quellen und Nachweise
- ORD-Eintrag
- ord-7c3b250014054028ae1647fcb20c6b75
- Quelldatensatz
- uspto-grants-1976_03
- Patentnummer
- US03947408
Verknüpfte Notizen
Wird geladen…